Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Brian Godman, Holly McCabe, Trudy D Leong, Debjani Mueller, Antony P. Martin, Iris Hoxha, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Juliana de Oliveira Costa, Renata Cristina Rezende Macedo do Nascimento, Livia Lovato Pires de Lemos, Konstantin Tachkov, Petya Milushewa, Okwen Patrick, Loveline Lum Niba, Ott Laius, Israel Sefah, Suhaj Abdulsalim, Fatemeh Soleymani, Anastasia N Guantai, Loice Achieng, Margaret Oluka, Arianit Jakupi, Konstantīns Logviss, Mohamed Azmi Hassali, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Zikria Saleem, Shazhad Hussain, Tomasz Bochenek, Ileana Mardare, Alian A. Alrasheedy, Jurij Furst, Dominik Tomek, Vanda Markovic-Pekovic, Enos M. Rampamba, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Aubrey Chichonyi Kalungia, Trust Zaranyika, Nyasha Masuka, Ioana D. Olaru, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell & Johanna C. Meyer. (2020) Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. Expert Review of Pharmacoeconomics & Outcomes Research 20:1, pages 1-26.
Read now
Read now
Christina Antza, Stella Stabouli & Vasilios Kotsis. (2016) Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Vascular Health and Risk Management 12, pages 443-451.
Read now
Read now
Emiliano Angeloni, Angelo Vitaterna, Paola Lombardo, Michele Pirelli & Simone Refice. (2015) Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis. Clinical and Experimental Hypertension 37:5, pages 404-410.
Read now
Read now
Claudio Borghi & Francesca Santi. (2012) Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence. Patient Preference and Adherence 6, pages 449-455.
Read now
Read now
Tomasz Stompór, Maria Napora & Artur Olszewski. (2011) Renoprotective effects of benazepril: current perspective. Expert Review of Cardiovascular Therapy 9:6, pages 663-673.
Read now
Read now
Vivencio Barrios & Carlos Escobar. (2010) Antihypertensive and organ-protective effects of benazepril. Expert Review of Cardiovascular Therapy 8:12, pages 1653-1671.
Read now
Read now
Vivencio Barrios & Carlos Escobar. (2010) Valsartan–amlodipine–hydrochlorothiazide: the definitive fixed combination?. Expert Review of Cardiovascular Therapy 8:11, pages 1609-1618.
Read now
Read now
Articles from other publishers (5)
Saif Ullah, Nizami Moazzam Syed, Tian Gang, Rana Shahzad Noor, Sarir Ahmad, Muhammad Mohsin Waqas, Adnan Noor Shah & Sami Ullah. (2022) Recent global warming as a proximate cause of deforestation and forest degradation in northern Pakistan. PLOS ONE 17:1, pages e0260607.
Crossref
Crossref
Jiajing Zhao, Yaohan Yue, Yun Xie, Liwen Liu, Fei Cao, Shurong Gao & Yingjue Wang. (2017) Radix Cyathula officinalis Kuan inhibits arterial remodeling in spontaneously hypertensive rats. Experimental and Therapeutic Medicine.
Crossref
Crossref
Joel M Neutel. (2013) Treatment algorithms for hypertension: a practical approach. Clinical Practice 10:3, pages 333-344.
Crossref
Crossref
Claudio Borghi & Arrigo F. G. Cicero. (2012) Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension. Clinical Drug Investigation 30:12, pages 843-854.
Crossref
Crossref
Carlos Escobar & Vivencio Barrios. (2010) Combined therapy in the treatment of hypertension. Fundamental & Clinical Pharmacology 24:1, pages 3-8.
Crossref
Crossref